Aromasin 25 mg Tablets

Exemestane belongs to a class of medications known as aromatase inhibitors, which work by permanently blocking the enzyme aromatase, responsible for converting other hormones into estrogen in the body. Since many breast cancers rely on estrogen to grow, reducing its production helps slow or stop the progression of hormone receptor-positive breast cancer. It is commonly used in postmenopausal women with early-stage or advanced breast cancer, either as an initial treatment or following other hormone therapies, particularly in patients whose disease has progressed on previous treatments. Exemestane is often used as part of adjuvant therapy following primary breast cancer treatment, helping reduce the risk of cancer recurrence over an extended treatment period. The tablets are taken orally, usually once daily after a meal, offering a convenient and consistent dosing schedule for long-term hormone therapy. Regular monitoring, including bone density checks and periodic follow-up imaging, is an important part of treatment to help support overall health and track the body's response over time. Many patients experience meaningful disease control and improved long-term outcomes with consistent use of Exemestane. Ongoing follow-up with an oncologist helps ensure the treatment remains appropriate and effective throughout the course of therapy. As with all hormone therapies for cancer treatment, Exemestane tablets should be used under the close supervision of a healthcare provider experienced in breast cancer care.